Cannabis Penny Stocks: Koios Sees Massive Gains for Nootropics Cannabis Drink

Penny Stocks

It’s Monday again! The first-weekend post cannabis legalization across Canada has come and gone. Despite all the green, cannabis penny stocks saw a lot of red in the last five days. 

But we start a new week with a stock that gained a very promising 27% last Friday. Let’s take a closer look at this stock, shall we?

Cannabis Penny Stocks: Koios Beverage Corp (CSE:KBEV)

Vancouver’s Koios Beverage Corp creates nootropic beverages—or beverages with a function. More traditionally, Koios’ formulas use superfoods and natural organic compounds to enhance brain and/or body activity. Areas such as focus, memory, fat burning, and concentration are some examples.

But now Koios will be adding cannabis to its ingredients as it looks to create the world’s first nootropic cannabis drink.

Enter Your E-mail Address To Subscribe

* indicates required
 

The first of two products is due for release soon; is this why this penny stock saw a massive price increase last Friday? Stocks climbed from $0.41 to $0.52. Will KBEV maintain this exponential growth as the week ticks along?

Cannabis Penny Stocks: New Nootropic Beverages

The new drink will blend cannabidiol, or CBD, with Koios’ usual nootropic formula and will utilize all the health benefits of CBD.

On the subject, Chris Miller, CEO and founder of Koios, said:

“CBD is the best researched of all the cannabinoids within the cannabis plant and is well known for its restorative effect on human health, and in dealing with various types of pain […] With our current nootropic stack we will bring a product to market that aims to produce high levels of natural focus while simultaneously creating calming effects for the end user.”

>> 2 Cheap Stocks that Could Climb AGAIN: Blink Charging and Pier 1

The second drink will be a collaborative effort with the company’s partner Keef Brands.

This drink will blend THC—the psychoactive compound in cannabis—with nootropic supplements from the Koios line of brain-enhancing functional beverages. It will be the first of its kind to combine cannabis infusion with nootropic supplements.

Koios Cannabis Penny Stocks

Koios is selling at a very attractive price for the potential market that lies in wait. Cannabis-infused drinks are set to be a multi-billion dollar industry. And Koios isn’t just entering into that market, it is entering it already with its nootropics niche in place. These new drinks can only bring good things for this company—a clever move in my opinion.

Check back in for more cannabis penny stocks! 

Featured Image: Depositphotos/© SergeyNivens